Each state in India has its specific policy, making it mandatory for importers, producers, and distributors to navigate the diverse and sometimes complex regulations.
Emergent BioSolutions Inc. (NYSE: EBS) today announced the exercise of contract option and modification valued at approximately $20 million to supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S.
“The government should further increase the quantity for Punjab as the supply is completely dry and the millers are dependent on FCI wheat. Also the auction should continue in the State till ...